Benjamin Garmezy, Arlene O. Siefker-Radtke, Andrae Lavon Vandross, Cesar Augusto Perez, Neal D. Shore, Daniel P. Petrylak, Mohammad Hirmand, Minal Mehta, Vadim S. Koshkin. "A phase 1/2, first-in-human study of AVZO-103, a bispecific Nectin4/Trop2 antibody-drug conjugate (ADC), as monotherapy and in combination therapy in patients with locally advanced or metastatic urothelial cancer (UC) or other solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps908